Income Statement
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $353K | — | -36.2% |
| Cost of Revenue | $290K | — | -25.1% |
| Gross Profit | $63K | — | -62.1% |
| R&D Expense | $153K | — | +12.2% |
| SG&A Expense | $1.4M | — | +68.9% |
| Operating Income | -$1.4M | — | -86.9% |
| Net Income | -$2.2M | — | -184.4% |
| EPS (Basic) | -$0.28 | — | -75.0% |
| EPS (Diluted) | -$0.28 | — | -75.0% |
Balance Sheet
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.2M | +311.2% | — |
| Accounts Receivable | $201K | +0.8% | — |
| Inventory | $105K | -10.1% | — |
| Current Assets | $4.7M | +219.5% | — |
| Total Assets | $5.8M | +40.3% | — |
| Current Liabilities | $2.6M | +4.7% | — |
| Total Liabilities | $3.0M | -26.7% | — |
| Stockholders' Equity | $2.6M | — | +140.2% |
Cash Flow
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.3M | — | -164.0% |
| Investing Cash Flow | -$5K | — | — |
| Financing Cash Flow | $4.5M | — | +1610.6% |